Aspiriant LLC decreased its holdings of Oracle Co. shares by 5.3% in the first quarter. The company sold over 1,000 shares, bringing its total to 20,866 shares valued at $2,621,000. Other hedge funds like Norges Bank and Vanguard Group also made changes to their holdings in Oracle. Internal activity in Oracle includes insider Edward Screven selling shares worth millions on June 20. Overall, insiders have sold over 300,000 shares in the last ninety days. Oracle’s stock fell by 0.7% to $138.25 on Thursday. The company’s financial performance showed a net margin of 19.76% and revenue of $14.29 billion for the last quarter. They also declared a quarterly dividend of $0.40 per share. Wall Street analysts have given Oracle stock various ratings, with a consensus price target of $145.83. Oracle offers a range of cloud software applications in its Oracle Cloud Software-as-a-Service offering.
In conclusion, Aspiriant LLC and other hedge funds have made adjustments to their holdings in Oracle, leading to changes in the company’s stock performance. Oracle insiders have been actively selling shares, and the firm recently declared a dividend. Wall Street analysts have offered varying opinions on the stock, with a consensus rating of “Moderate Buy”. Oracle continues to offer cloud software applications as part of its services.
Article Source
https://www.defenseworld.net/2024/06/27/aspiriant-llc-has-2-62-million-holdings-in-oracle-co-nyseorcl.html
